2015 SABCS 年度回顾-早期乳腺癌.pptx

SABCS2015 早期乳腺癌年度回顾Early breast cancer-More or Less?仅供医疗专业人士参考审批号/有效期至：ER阳性乳腺癌-“更少”的治疗至今我们知晓哪些？ 化疗对部分ER阳性的乳腺癌 并非是必须的（TAILORx，S1-08*）我们是否清楚哪些患者需要延长辅助治疗？是否所有患者都需要延长辅助治疗？（ASCO BCI）哪些患者需要“更多”的治疗？ （S2-02**: The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial）*High risk premenopausal luminal A breast cancer patients derive no benefit from adjuvant chemotherapy: Results from DBCG77B randomized trial**The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trialTrial As